← FDA Drug Approvals (Drugs@FDA)

SODIUM NITROPRUSSIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AVET LIFESCIENCES · Approved 2022-11-08

Drug application

FDA Application #
ANDA208923
Application type
Abbreviated New Drug Application (Generic)
Brand name
SODIUM NITROPRUSSIDE
Generic name
Sodium Nitroprusside
Active ingredients
SODIUM NITROPRUSSIDE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Discontinued
Sponsor
AVET LIFESCIENCES
First approval
2022-11-08

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown